首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Engineering

缩写:ENGINEERING-PRC

ISSN:2095-8099

e-ISSN:2096-0026

IF/分区:12.2/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引94
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Hongmin Sun,Xingxing Li,Minghua Chen et al. Hongmin Sun et al.
Many microorganisms have mechanisms that protect cells against attack from viruses. The fermentation components of Streptomyces sp. 1647 exhibit potent anti-influenza A virus (IAV) activity. This strain was isolated from soil in southern Ch...
Shasha Han,Ting Zhang,Yan Lyu et al. Shasha Han et al.
Seasonal influenza activity typically peaks in the winter months but plummeted globally during the current coronavirus disease 2019 (COVID-19) pandemic. Unraveling lessons from influenza's unprecedented low profile is critical in informing ...
Yuliang Xie,Ryan Becker,Michael Scott et al. Yuliang Xie et al.
COVID-19, an infectious pulmonary disease caused by the SARS-CoV-2 virus, has profoundly impacted the world, motivating researchers across a broad spectrum of academic disciplines to gain a deeper understanding and develop effective therapi...
Zhiming Huang,Zhihao Fu,Junzhi Wang Zhiming Huang
Regulatory science is a discipline that uses comprehensive methods of natural science, social science, and humanities to provide support for administrative decision-making through the development of new tools, standards, and approaches to a...
Yahan Lu,Lixing Yang,Kai Yang et al. Yahan Lu et al.
Regular coronavirus disease 2019 (COVID-19) epidemic prevention and control have raised new requirements that necessitate operation-strategy innovation in urban rail transit. To alleviate increasingly serious congestion and further reduce t...
Lu Zhao,Hao Liu,Yingchao Wang et al. Lu Zhao et al.
Xuanfeibaidu Formula (XFBD) is a Chinese medicine used in the clinical treatment of coronavirus disease 2019 (COVID-19) patients. Although XFBD has exhibited significant therapeutic efficacy in clinical practice, its underlying pharmacologi...
Shui Hu,Hongchi Tian,Shijia Zhang et al. Shui Hu et al.
The coronavirus disease 2019 (COVID-19) pandemic has caused a surge in demand for face masks, with the massive consumption of masks leading to an increase in resource-related and environmental concerns. In this work, we fabricated meltblown...
Lin Li,Yuzheng Wu,Jiabao Wang et al. Lin Li et al.
Traditional Chinese medicine (TCM) has been successfully applied worldwide in the treatment of coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, the pharmacologica...
Simiao Chen,Hui Sun,Mei Heng et al. Simiao Chen et al.
Most studies of coronavirus disease 2019 (COVID-19) progression have focused on the transfer of patients within secondary or tertiary care hospitals from regular wards to intensive care units. Little is known about the risk factors predicti...